Small RNAs might drive COPD progression: Research lays foundation for potential new diagnostics and therapies

Chronic obstructive pulmonary disease (COPD) affects nearly 12 million people in the U.S. alone and is the third leading cause of death worldwide. High levels of immune molecules known as cytokines, which can damage the lungs, are a hallmark of COPD.

This article was originally published on MedicalXpress.com

You may also be interested in:

Read More:

Lawyers Lookup